23:08 | 22nd April 2019

World News: Treatment News Archive

May 20th: New HIV Vaccine To Be Trialled In South Africa

An experimental HIV vaccine that's worked better than anything else tried so far is going to be tested in South Africa, U.S. health officials said Wednesday.

Mar 29th: NICE recommends unrestricted access to 'Victrelis'®▼

National Institute for Health and Clinical Excellence (NICE) in the UK has issued a Final Appraisal Determination (FAD) recommending the use of 'Victrelis'® (boceprevir) in combination with peginterferon alfa and ribavirin ('dual therapy') as an option for the treatment of genotype 1 chronic hepatitis C

Mar 29th: New US treatment guidelines reccomend antiretrovirals for all with HIV

Newly updated US antiretroviral treatment guidelines are recommending antiretroviral treatment for all people with HIV infection, with particular emphasis on treatment for: people with CD4 cell counts below 500

Feb 24th: Phase II Hepatitis C Treatment Published by BMS

Bristol-Myers Squibb Company (NYSE: BMY) has announced the full results, published in the New England Journal of Medicine, from a Phase II clinical trial in patients with hepatitis C virus (HCV) genotype 1 who had not responded to prior therapy with PEG-interferon alfa and ribavirin (‘null responders’*).